What drugs does PIRAMAL make?

PIRAMAL has 7 FDA-approved drugs including OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE.

What therapeutic areas does PIRAMAL focus on?

PIRAMAL focuses primarily on Cardiovascular and Neurology.

← Back

Data updated: Mar 10, 2026

PIRAMAL

CardiovascularNeurology

Generics

PIRAMAL is a generic drug manufacturer focused on Cardiovascular, Neurology.

2018

Since

Drugs

Trials

Approved (2yr)

Key Drugs

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

amlodipine besylate

Cardiovascular

AT1 receptor 3 indications · 2016

Recent Activity

VARENICLINE TARTRATE 2026-01-09

VARENICLINE TARTRATE 2025-12-18

Labeling

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 2025-11-24

CISATRACURIUM BESYLATE 2025-11-03

Labeling

VARENICLINE TARTRATE 2025-10-29

DEFERASIROX 2025-10-21

Labeling

DEFERASIROX 2025-10-21

Labeling

DEFERASIROX 2025-10-21

Labeling

DEFERASIROX 2025-10-21

Labeling

DEFERASIROX 2025-10-21

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 92%

2 drugs

Neurology 8%

0 drugs Phase 1: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

GE HEALTHCARE specialty

Neurology, Cardiovascular

Novo Nordisk big-pharma

Cardiovascular, Neurology

LEDERLE big-pharma

Cardiovascular, Neurology

PAI HOLDINGS PHARM big-pharma

Neurology, Cardiovascular

VALIDUS PHARMS specialty

Cardiovascular, Neurology

PIRAMAL

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (7)

Active (5)

Discontinued (2)

Company Info